ERBB2 and neoplasm: PI3K-AKT is a signaling pathway involved in cell proliferation, survival, invasion, and migration which is a key character of tumor growth, especially since up to 40% of PIK3CA mutations are estrogen receptor(ER) positive and human epidermal growth factor receptor2 (HER2)-negative in primary and metastatic breast cancer.